{
  "id": "clinical#screening_cues_3893a0bd",
  "content": "A diagnosis of neuroleptic malignant syndrome is based on the clinical judgement that exposure\nto an antipsychotic medication or other dopamine receptor-blocking agents is the cause of the\nsymptoms. This distinction can be difficult because many individuals who develop catatonia take\nantipsychotic medication. It is made based on the timing of the symptoms in relation to medication\nuse, prior history of multiple episodes of catatonia (in which case neuroleptic malignant syndrome is\nless likely), and sometimes the presence of certain medical complications that are not characteristic\nof catatonia, such as hyperkalaemia or liver or kidney failure.\nBoundary of catatonia with serotonin syndrome\nSymptoms of serotonin syndrome include agitation or restlessness and muscle rigidity, as well as\nautonomic disturbances such as high fever and tachycardia, which may also occur in catatonia. A\ndiagnosis of serotonin syndrome involves the clinical judgement that exposure to a serotonergic\nmedication or an interaction between serotonergic medications (e.g. when increasing the dose of a\nmedication or adding a new medication) is the cause of the symptoms, based on the timing of the\nsymptoms in relation to medication use. Serotonin syndrome is more likely to present with tremor,",
  "metadata": {
    "source": "WHO ICD-11",
    "url": "https://icd.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "communication_tips",
      "screening_cues",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General â€” Screening Cues A diagnosis of neuroleptic malignant syndrome is based on the clinical judgement that exposure\nto an antipsychotic medication or other dopamine receptor-blocking agents is the cause of the\nsymptoms. This distinction can be difficult because many individuals who develop catatonia take\nantipsychotic medication. It is made based on the timing of the symptoms in relation to medication\nuse, prior history of multiple episodes of catatonia (in which case neuroleptic malignant syndrome is\nless likely), and sometimes the presence of certain medical complications that are not characteristic\nof catatonia, such as hyperkalaemia or liver or kidney failure.\nBoundary of catatonia with serotonin syndrome\nSymptoms of serotonin syndrome include agitation or restlessness and muscle rigidity, as well as\nautonomic disturbances such as high fever and tachycardia, which may also occur in catatonia. A\ndiagnosis of serotonin syndrome involves the clinical judgement that exposure to a serotonergic\nmedication or an interaction between serotonergic medications (e.g. when increasing the dose of a\nmedication or adding a new medication) is the cause of the symptoms, based on the timing of the\nsymptoms in relation to medication use. Serotonin syndrome is more likely to present with tremor, A diagnosis of neuroleptic malignant syndrome is based on the clinical judgement that exposure\nto an antipsychotic medication or other dopamine receptor-blocking agents is the cause of the\nsymptoms. this distinction can ..."
}